MedPath

Clinical Study Of Raal churna (resin of shorea robusta) And Nagkeshara(Mesua ferrea Linn.) Churna In the treatment Of White vaginal Discharge(Leucorrhoea) in females.

Phase 2
Conditions
Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs
Registration Number
CTRI/2022/12/047900
Lead Sponsor
Government Dhanvantari Ayurvedic College And Hospital Ujjain
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Married Female Patients Of Age 18 to 55 Years

2 Patients Presenting With Complaints Of White Discharge Per Vginum

3 Patients Willing To Register And Sign The Consent Form

Exclusion Criteria

1 Unmarried female

2 Patient having any type of malignancy

3 Patient having positive VDRL HIV HbsAg Tuberculosis Pelvic inflammatory diseases and STDs

4 Pregnant women and Lactating Mothers

5 Patient having any Chronic systemic Illness

6 Age below 18 year and above 55 year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)Timepoint: Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)
Secondary Outcome Measures
NameTimeMethod
Assessment of change in the clinical parameters on 15th dayTimepoint: 30th and 45th day
© Copyright 2025. All Rights Reserved by MedPath